Health Canada has granted Medtronic approval for its SureTune3 software, which facilitates physicians' decision-making in deep brain stimulation therapy programming using patient-specific visualization of lead location and simulated neural activation volume. The software comes with a 3D deformable atlas to enable physicians to precisely define anatomical structures.
Health Canada OKs Medtronic's SureTune3 DBS software
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.